drugset / Trial / NCT02849236

PECS I Block for Breast Subpectoral Implant Surgery

NCT02849236 ↗

Completed 56 enrolled University Hospital, Lille
RandomizedParallel-groupTriple-blindTreatment

Summary

Breast augmentation surgery can cause important postoperative pain, especially when bilateral subpectoral implants are used. The investigators hypothesized that a technique of regional analgesia, the pectoral nerve block type I (or "PECS I block") would reduce pain within the first twenty-four hours and, in turn, morphine consumption and associated side effects. This is a randomized, controlled, double-blind study which compares intra and postoperative analgesia with or without PECS I block in breast surgery.

Timeline

Start
2016-10-16
Primary completion
2020-07
Completion
2020-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Ropivacaine Other / unclassified 3.75 mg/ml Other

Indications